FRIEDL; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for FRIEDL; Thomas.The latest application filed is for "dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation".

Company Profile

2.19.58

FRIEDL; Thomas - Ochsenhausen DE
Friedl; Thomas - Goettingen DE
Friedl; Thomas - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dpp-iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation App 20210196722 - FRIEDL; Thomas ; et al.	2021-07-01
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation Grant 10,973,827 - Friedl , et al. April 13, 2	2021-04-13
Dpp-iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For The App 20200069693 - FRIEDL; Thomas ; et al.	2020-03-05
Dpp-iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation App 20180289716 - FRIEDL; Thomas ; et al.	2018-10-11
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation Grant 10,022,379 - Friedl , et al. July 17, 2	2018-07-17
Dpp-iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation App 20170119773 - FRIEDL; Thomas ; et al.	2017-05-04
Dpp-iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation App 20160310435 - FRIEDL; Thomas ; et al.	2016-10-27
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation Grant 9,415,016 - Friedl , et al. August 16, 2	2016-08-16
Pharmaceutical compositions containing flibanserin App 20160095819 - Friedl; Thomas ; et al.	2016-04-07
Dpp-iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation App 20150366812 - FRIEDL; Thomas ; et al.	2015-12-24
Pharmaceutical Compositions for the Treatment of Sexual Disorders II App 20150320739 - Mendla; Klaus ; et al.	2015-11-12
DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation Grant 9,155,705 - Friedl , et al. October 13, 2	2015-10-13
Pharmaceutical compositions containing flibanserin App 20150004228 - Friedl; Thomas ; et al.	2015-01-01
Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof App 20140335175 - FRIEDL; Thomas ; et al.	2014-11-13
Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof Grant 8,715,728 - Friedl , et al. May 6, 2	2014-05-06
Extended release tablet formulations of flibanserin and method for manufacturing the same Grant 8,658,207 - Eisenreich , et al. February 25, 2	2014-02-25
Pharmaceutical compositions containing flibanserin App 20140010878 - Friedl; Thomas ; et al.	2014-01-09
Bilayer Pharmaceutical Tablet Comprising Telmisartan and a Diuretic and Preparation Thereof App 20130309307 - FRIEDL; Thomas ; et al.	2013-11-21
Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof App 20130274300 - FRIEDL; Thomas ; et al.	2013-10-17
Extended release tablet formulations of flibanserin and method for manufacturing the same Grant 8,545,886 - Eisenreich , et al. October 1, 2	2013-10-01
Solid pharmaceutical formulations comprising BIBW 2992 Grant 8,545,884 - Messerschmid , et al. October 1, 2	2013-10-01
Process For Preparing Orally Administered Dabigatran Formulations App 20130251810 - LANDERER; Sabine ; et al.	2013-09-26
Controlled release system and method for manufacturing the same Grant 8,512,748 - Pearnchob , et al. August 20, 2	2013-08-20
Pharmaceutical Compositions for the Treatment of Sexual Disorders II App 20130203766 - Mendla; Klaus ; et al.	2013-08-08
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof Grant 8,377,977 - Friedl , et al. February 19, 2	2013-02-19
Extended Release Formulation App 20120282338 - FRIEDL; Thomas ; et al.	2012-11-08
Modified Release Formulation App 20120282337 - FRIEDL; Thomas ; et al.	2012-11-08
Tablet Formulation App 20120012499 - Wada; Koichi ; et al.	2012-01-19
Microalga species and its application for animal, human consumption and in obtaining carotenoids Grant 8,067,225 - Fernandez Sevilla , et al. November 29, 2	2011-11-29
Dpp-iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation App 20110206766 - Friedl; Thomas ; et al.	2011-08-25
Extended Release Formulation App 20110195122 - FRIEDL; Thomas ; et al.	2011-08-11
Modified Release Formulation App 20110150994 - FRIEDL; Thomas ; et al.	2011-06-23
Solid Pharmaceutical Formulations Comprising Bibw 2992 App 20110142929 - Messerschmid; Roman ; et al.	2011-06-16
Process For Preparing Orally Administered Dabigatran Formulations App 20110129538 - Landerer; Sabine ; et al.	2011-06-02
Pharmaceutical Compositions for the Treatment of Sexual Disorders II App 20110105519 - Mendla; Klaus ; et al.	2011-05-05
Pharmaceutical Composition Comprising A Monoamine Neurotransmitter Re-uptake Inhibitor And An Acetylcholinesterase Inhibitor App 20100210626 - FRIEDL; Thomas ; et al.	2010-08-19
Solid Pharmaceutical Preparation App 20100178342 - Brauns; Ulrich ; et al.	2010-07-15
Pharmaceutical Formulation Comprising Pramipexole App 20100168191 - Reess; Juergen ; et al.	2010-07-01
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof Grant 7,695,734 - Friedl , et al. April 13, 2	2010-04-13
Extended Release Pellet Formulation Containing Pramipexole Or A Pharmaceutically Acceptable Salt Thereof App 20100086589 - FRIEDL; Thomas ; et al.	2010-04-08
Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof App 20090281153 - FRIEDL; Thomas ; et al.	2009-11-12
Tablet Formulation App 20090252790 - Wada; Koichi ; et al.	2009-10-08
Bilayer Pharmaceutical Tablet Comprising Telmisartan And A Diuretic And Preparation Thereof App 20090227802 - FRIEDL; Thomas ; et al.	2009-09-10
Extended Release Tablet Formulation Containing Pramipexole Or A Pharmaceutically Acceptable Salt Thereof App 20090182024 - FRIEDL; Thomas ; et al.	2009-07-16
Extended Release Pellet Formulation Containing Pramipexole Or A Pharmaceutically Acceptable Salt App 20090130197 - Friedl; Thomas ; et al.	2009-05-21
Microalga Species And Its Application For Animal, Human Consumption And In Obtaining Carotenoids App 20090117223 - Fernandez Sevilla; Jose Maria ; et al.	2009-05-07
Extended Release Formulation App 20090098202 - Friedl; Thomas ; et al.	2009-04-16
Modified Release Formulation App 20090041844 - Friedl; Thomas ; et al.	2009-02-12
Pharmaceutical compositions for the treatment of sexual disorders II App 20080103155 - Mendla; Klaus ; et al.	2008-05-01
Controlled release system and method for manufacturing the same App 20080069873 - Pearnchob; Nantharat ; et al.	2008-03-20
Extended release tablet formulations of flibanserin and method for manufacturing the same App 20080038347 - Eisenreich; Wolfram ; et al.	2008-02-14
Extended release tablet formulations of flibanserin and method for manufacturing the same App 20080038346 - Eisenreich; Wolfram ; et al.	2008-02-14
Gastro Retentive Delivery System App 20080031945 - EISENREICH; Wolfram ; et al.	2008-02-07
Solid Pharmaceutical Form Comprising and Ltb4 Antagonist App 20070237823 - Bock; Thomas ; et al.	2007-10-11
Pharmaceutical compositions containing flibanserin App 20070196473 - FRIEDL; Thomas ; et al.	2007-08-23
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof App 20060198887 - Friedl; Thomas ; et al.	2006-09-07
Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof App 20060051419 - Friedl; Thomas ; et al.	2006-03-09
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof App 20060051417 - Friedl; Thomas ; et al.	2006-03-09
Pharmaceutical compositions for the treatment of sexual disorders II App 20050245539 - Mendla, Klaus ; et al.	2005-11-03
Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist App 20050182089 - Friedl, Thomas ; et al.	2005-08-18
Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor App 20050154009 - Friedl, Thomas ; et al.	2005-07-14
Solid pharmaceutical preparation App 20050124651 - Brauns, Ulrich ; et al.	2005-06-09
Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof App 20050089575 - Friedl, Thomas ; et al.	2005-04-28
Administration form for the oral application of poorly soluble acidic and amphorteric drugs App 20050053669 - Friedl, Thomas ; et al.	2005-03-10
Medical formulation containing a muscarinic agonist App 20050008703 - Bechtold-Peters, Karoline ; et al.	2005-01-13
Pharmaceutical compositions containing flibanserin App 20040048877 - Friedl, Thomas ; et al.	2004-03-11
Medical formulation containing a muscarinic agonist App 20020160048 - Bechtold-Peters, Karoline ; et al.	2002-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.